NBIXNeurocrine Biosciences, Inc.

CUSIP: 64125C109

Guru Owners

$802.5M

Total Value Held

5.7M

Total Shares

Investor	Fund	Shares	Value▼	% of Portfolio	Rpt Price	Period
Dodge & Cox	Dodge & Cox	5508042	$781.2M	0.42%	$141.83	Q4 2025
Ray Dalio	Bridgewater Associates	149990	$21.3M	0.08%	$141.83	Q4 2025

Dodge & Cox

$781.2M

0.42%

Ray Dalio

$21.3M

0.08%

📊 Fundamentals

Market Cap$12.9B

P/E Ratio27.5x

Above market avg

Forward P/E13.4x

P/FCF32.3x

EPS (TTM)$4.66

Revenue (TTM)$2.9B

Profit Margin16.73%

Beta0.36

52-Week Range

$84.23

$160.18

Current: $128.13

Data from Yahoo Finance · refreshed every 4 hours

💡 Trades at 27.5x trailing earnings → 13.4x forward · 16.7% profit margin

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

Quarter-by-Quarter Activity

Q4 '252 owners · $802.5M

REDUCEDDodge & Cox$781.2M

REDUCEDRay Dalio$21.3M

Q3 '252 owners · $783.3M

REDUCEDDodge & Cox$780.0M

REDUCEDRay Dalio$3.2M

Q2 '252 owners · $700.8M

INCREASEDDodge & Cox$699.7M

INCREASEDRay Dalio$1.1M

Q1 '252 owners · $621.8M

INCREASEDDodge & Cox$612.1M

INCREASEDRay Dalio$9.6M

Q4 '242 owners · $457.1M

NEWDodge & Cox$411.7M

INCREASEDRay Dalio$45.4M

Q3 '241 owners · $15.6M

REDUCEDRay Dalio$15.6M

SOLDDodge & Cox

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

📊 Adjust the assumptions below to calculate an estimated fair value

Projection Period

Revenue Growth Rate

10%analyst est. 10.2%

0%100%

Growth Decay Rate

15%

0% (no decay)50% (fast decay)

Terminal Growth Rate

3.0%

0%5%

FCF Margin

13.9%current: 13.9%

1%50%

Discount Rate (WACC)

8.0%typical: 8% large caps · 10% growth

5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data

🏛️ Congressional Trades

NBIX: Held by 2 superinvestors · 3 congress member trades

SELLLisa McClainR

$1,001 - $15,0002025-06-17

BUYLisa McClainR

$1,001 - $15,0002025-06-11

SELLMichael McCaulR

$15,001 - $50,0002024-11-19